BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12939865)

  • 1. [Possible role of mucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases].
    Müzes G
    Orv Hetil; 2003 Jul; 144(29):1441-6. PubMed ID: 12939865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraintestinal manifestations of inflammatory bowel disease.
    Urlep D; Mamula P; Baldassano R
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD.
    Salmi M; Jalkanen S
    Inflamm Bowel Dis; 1998 May; 4(2):149-56. PubMed ID: 9589300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.
    Agrawal D; Rukkannagari S; Kethu S
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):233-48. PubMed ID: 17912186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.
    Grant AJ; Lalor PF; Salmi M; Jalkanen S; Adams DH
    Lancet; 2002 Jan; 359(9301):150-7. PubMed ID: 11809275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
    Grant AJ; Lalor PF; Hübscher SG; Briskin M; Adams DH
    Hepatology; 2001 May; 33(5):1065-72. PubMed ID: 11343233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extra-intestinal manifestations].
    Descos L
    Rev Prat; 1991 Feb; 41(5):415-8. PubMed ID: 2011689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extraintestinal manifestations of inflammatory bowel diseases and their management].
    Garamszegi M
    Orv Hetil; 2011 Apr; 152(17):663-71. PubMed ID: 21464024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.
    Evans PE; Pardi DS
    MedGenMed; 2007 Mar; 9(1):55. PubMed ID: 17435655
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of homing receptor CD103 on lamina propria lymphocytes and association of CD103 with epithelial adhesion molecules in inflammatory bowel disease.
    Oshitani N; Watanabe K; Maeda K; Fujiwara Y; Higuchi K; Matsumoto T; Arakawa T
    Int J Mol Med; 2003 Nov; 12(5):715-9. PubMed ID: 14532999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extraintestinal manifestations of chronic inflammatory intestinal disease].
    Berges Magaña MA; Castillo Grau P; Patrón Costas G; Rodríguez Blanes JA; Muñoz Núñez F; Presa Valle M; González Murillo M; Suárez de Parga JM
    Rev Clin Esp; 1992 Nov; 191(8):435-40. PubMed ID: 1488518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: thinking outside of the intestines (Part 1).
    Ricker JM; Harrison SA
    J Miss State Med Assoc; 2008 Dec; 49(12):359-64. PubMed ID: 19297931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extraintestinal complications of inflammatory bowel disease].
    Nagasaka M; Fujita H; Kamano T; Komura N; Hirata I
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():406-10. PubMed ID: 23126127
    [No Abstract]   [Full Text] [Related]  

  • 15. Extraintestinal manifestations and complications in inflammatory bowel diseases.
    Rothfuss KS; Stange EF; Herrlinger KR
    World J Gastroenterol; 2006 Aug; 12(30):4819-31. PubMed ID: 16937463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraintestinal manifestations.
    Present DH
    Mt Sinai J Med; 1983; 50(2):126-32. PubMed ID: 6602277
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel diseases: Part II. Extraintestinal involvement and management.
    Gitnick G
    Am Fam Physician; 1989 Feb; 39(2):225-33. PubMed ID: 2644791
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease.
    Eksteen B; Miles AE; Grant AJ; Adams DH
    Clin Med (Lond); 2004; 4(2):173-80. PubMed ID: 15139741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic manifestations associated with chronic inflammatory bowel diseases].
    Bouhnik Y; Benamouzig R; Rybojad M; Matuchansky C; Rambaud JC
    Gastroenterol Clin Biol; 1993; 17(2):121-9. PubMed ID: 8500699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.